GWPH up +1.57% percent Today $GWPH High is at 77.2
Post# of 82
Posted On: 11/13/2014 12:11:24 PM
GWPH up +1.57% percent Today $GWPH High is at 77.20 and the Low 74.75 with current volume of 63,889.
Recent News posted below.
Gw Pharmaceuticals Plc Ads GWPH other info.
http://investorshangout.com/GW-Pharmaceuticals-GWPH-62459/
GWPH Gw Pharmaceuticals Plc Ads Recent Headline News
Why GW Pharmaceuticals (GWPH) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:46AM CST
GW Pharmaceuticals has decent short-term momentum and is also seeing solid activity on the earnings estimate revision front for the coming quarter and year.
GWPH: 75.46 (+0.14)
Allscripts Healthcare and CHI Sign Hosting Solution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:40PM CST
By utilizing Allscripts Healthcare Solutions, Inc. (MDRX) Hosting Solution, Catholic Health Initiatives expects improved system availability, reduced IT infrastructure expenditures as well as enhanced end user performance.
GWPH: 75.46 (+0.14), ABAX: 55.12 (+0.92), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)
INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 84.00 (-0.73), INSY: 38.14 (-1.51), ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14)
Omeros (OMER) Catches Eye: Stock Jumps 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:30AM CST
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise almost 9% on the day.
ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12), OMER: 19.30 (-0.41)
Insys Q3 Beats Estimates, Helping Stock Rebound
at Investor's Business Daily - Tue Nov 11, 10:33AM CST
Specialty drugmaker Insys Therapeutics (INSY) beat Wall Street's Q3 estimates Tuesday, sending the stock up around 6% in early trading on the stock market today. Insys' revenue in the quarter totaled $58.3 million, double the year-earlier quarter and...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), TEVA: 57.96 (-0.48), GSK: 45.72 (+0.10)
CannLabs; Growing a Presence in a Burgeoning Industry
ACCESSWIRE - Tue Nov 11, 8:56AM CST
WHITEFISH, MT / ACCESSWIRE / November 11, 2014 / The U.S. cannabis industry could reach between $21 billion and $35 billion by 2020, according to Green Wave Advisors, depending on the number of states that successfully legalize the drug over the coming years. As more states implement their own programs, there is a growing need for high-quality testing services in order to ensure high-quality and safe products for both medical and recreational users.
GWPH: 75.46 (+0.14)
Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), EGRX: 12.75 (-0.05)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 75.46 (+0.14)
Cannabix Marijuana Breathalyzer Could Help Separate Users From Impaired
ACCESSWIRE - Mon Nov 10, 8:48AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Federal Schedule I regulations on medical marijuana (MMJ) and recreational use are changing with each passing day as states continue to hammer out their own policy frameworks, spurred on by sizeable additions to state coffers as a result of tax revenues. Pew Research Center survey data from earlier this year also shows that for the first time since 1969, when only 12% of Americans favored legalization, more than half (54%) the country is now in favor of making marijuana legal. With 23 states and D.C. now having either some form of MMJ legislation, or open recreational use on the books (as in Colorado and Washington), cash-strapped state budget makers are likely looking closely at data points like the Denver Business Journal's analysis of Colorado's recreational market, which forecasts around $70M in tax revenues this fiscal year. In Oregon, where a ballot vote for legalization is set to take place in November, the state's Legislative Revenue Office estimates 2017 tax revenues at around $16M as a result. Recent in-depth analysis by NerdWallet even put the upper limit for Oregon around $100M per annum, and with a nationwide projection of as much as $3.1B, it seems clear that the tax revenue factor could lead to more easing from the feds. On November 4th, Washington D.C. voters looked to join Colorado and Washington State in legalizing adult-use marijuana after backing Initiative 71 at the voting booths. With voters backing the bill 7-to-3, the initiative will permit anyone over the age of 21 to legally possess as much as two ounces of marijuana and to grow up to three marijuana plants at home.
GWPH: 75.46 (+0.14)
Meridian Bioscience (VIVO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:55AM CST
Meridian Bioscience saw a big move last session, as the company’s shares fell by nearly 6% which continued the recent downtrend
VIVO: 16.64 (-0.24), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12)
Medical Marijuana Receives Mixed Signals With This Latest Study
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 10:44AM CST
Source: Flickr user Matthew Kenwrick. The results of the midterm elections were mixed for supporters of marijuana legalization, though mostly positive. Hopes were high that the states of Oregon and Alaska, as well as Washington, D.C., would...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)
The Important Lesson Learned From Florida's Medical Marijuana Vote
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 11:26AM CST
Source: Flickr user Mark. Midterm elections may be over, but that doesn't mean the number of issues that Congress and individual states are yet to tackle have been moved to the back burner. One particular hot-button issue that took center stage...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)
3 Approve Marijuana Measures, but Florida Passes on Pot
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:09AM CST
Source: Architect of the Capitol, Flickr. Marijuana advocates are cheering the approval of recreational marijuana in Oregon, Alaska, and the District of Columbia, but supporters in Florida will need to shift their focus to 2016. Marijuana is...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), LVS: 63.01 (+1.44)
Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)
Wright Medical Posts Wider Q3 Loss; Lowers '14 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:50AM CST
Following the earnings release, shares of Wright Medical Group Inc. (WMGI) dropped nearly 5.7% to close at $28.44 yesterday.
BSX: 13.38 (-0.03), WMGI: 28.59 (+0.39), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), HSP: 57.87 (-0.22)
Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 75.46 (+0.14)
Cannagrow Holdings, Inc. (CGRW) Establishes Itself As a Leader In Colorado's Expanding Cannabis Industry
ACCESSWIRE - Thu Nov 06, 7:01AM CST
Salt Lake City, UT / ACCESSWIRE / November 6, 2014 / As Cannagrow Holdings, Inc. (CGRW) further establishes itself in Colorado and strengthens its association with licensed cannabis growers in the region, cannabis measures voted into law on election day in several states should place CGRW in an ideal position to see substantial gains in a cannabis market that could prove to be far larger than anyone could have predicted over the next two to three years.
GWPH: 75.46 (+0.14)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 69.38 (+0.88), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), COV: 93.87 (+0.99)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), SPHS: 2.55 (-0.07)
Recent News posted below.
Gw Pharmaceuticals Plc Ads GWPH other info.
http://investorshangout.com/GW-Pharmaceuticals-GWPH-62459/
GWPH Gw Pharmaceuticals Plc Ads Recent Headline News
Why GW Pharmaceuticals (GWPH) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:46AM CST
GW Pharmaceuticals has decent short-term momentum and is also seeing solid activity on the earnings estimate revision front for the coming quarter and year.
GWPH: 75.46 (+0.14)
Allscripts Healthcare and CHI Sign Hosting Solution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:40PM CST
By utilizing Allscripts Healthcare Solutions, Inc. (MDRX) Hosting Solution, Catholic Health Initiatives expects improved system availability, reduced IT infrastructure expenditures as well as enhanced end user performance.
GWPH: 75.46 (+0.14), ABAX: 55.12 (+0.92), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)
INSYS Therapeutics (INSY) in Focus: Stock Rises 12% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:44AM CST
INSYS Therapeutics, Inc. (INSY) was a big mover last session, as the company saw its shares surge 12%
ICUI: 84.00 (-0.73), INSY: 38.14 (-1.51), ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14)
Omeros (OMER) Catches Eye: Stock Jumps 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:30AM CST
Omeros Corporation (OMER) was a big mover last session, as the company saw its shares rise almost 9% on the day.
ABAX: 55.12 (+0.92), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12), OMER: 19.30 (-0.41)
Insys Q3 Beats Estimates, Helping Stock Rebound
at Investor's Business Daily - Tue Nov 11, 10:33AM CST
Specialty drugmaker Insys Therapeutics (INSY) beat Wall Street's Q3 estimates Tuesday, sending the stock up around 6% in early trading on the stock market today. Insys' revenue in the quarter totaled $58.3 million, double the year-earlier quarter and...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), TEVA: 57.96 (-0.48), GSK: 45.72 (+0.10)
CannLabs; Growing a Presence in a Burgeoning Industry
ACCESSWIRE - Tue Nov 11, 8:56AM CST
WHITEFISH, MT / ACCESSWIRE / November 11, 2014 / The U.S. cannabis industry could reach between $21 billion and $35 billion by 2020, according to Green Wave Advisors, depending on the number of states that successfully legalize the drug over the coming years. As more states implement their own programs, there is a growing need for high-quality testing services in order to ensure high-quality and safe products for both medical and recreational users.
GWPH: 75.46 (+0.14)
Eagle Pharmaceuticals (EGRX) Jumps: Stock Gains 8.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 8:46AM CST
Eagle Pharmaceuticals (EGRX) was a big mover last session, with shares rising over 8% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), EGRX: 12.75 (-0.05)
Cannabis Legalization Wins Out in Midterm Elections
ACCESSWIRE - Mon Nov 10, 10:00AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Cannabis stocks moved lower over the past week, according to data from the MarijuanaIndex(TM), despite favorable outcomes in the mid-term elections. Industry bellwethers, like GW Pharmaceuticals plc (NASDAQ: GWPH), traded largely sideways, although MedBox Inc. (OTC: MDBX) fell more than 20%.
GWPH: 75.46 (+0.14)
Cannabix Marijuana Breathalyzer Could Help Separate Users From Impaired
ACCESSWIRE - Mon Nov 10, 8:48AM CST
WHITEFISH, MT / ACCESSWIRE / November 10, 2014 / Federal Schedule I regulations on medical marijuana (MMJ) and recreational use are changing with each passing day as states continue to hammer out their own policy frameworks, spurred on by sizeable additions to state coffers as a result of tax revenues. Pew Research Center survey data from earlier this year also shows that for the first time since 1969, when only 12% of Americans favored legalization, more than half (54%) the country is now in favor of making marijuana legal. With 23 states and D.C. now having either some form of MMJ legislation, or open recreational use on the books (as in Colorado and Washington), cash-strapped state budget makers are likely looking closely at data points like the Denver Business Journal's analysis of Colorado's recreational market, which forecasts around $70M in tax revenues this fiscal year. In Oregon, where a ballot vote for legalization is set to take place in November, the state's Legislative Revenue Office estimates 2017 tax revenues at around $16M as a result. Recent in-depth analysis by NerdWallet even put the upper limit for Oregon around $100M per annum, and with a nationwide projection of as much as $3.1B, it seems clear that the tax revenue factor could lead to more easing from the feds. On November 4th, Washington D.C. voters looked to join Colorado and Washington State in legalizing adult-use marijuana after backing Initiative 71 at the voting booths. With voters backing the bill 7-to-3, the initiative will permit anyone over the age of 21 to legally possess as much as two ounces of marijuana and to grow up to three marijuana plants at home.
GWPH: 75.46 (+0.14)
Meridian Bioscience (VIVO) Falls: Stock Goes Down 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 7:55AM CST
Meridian Bioscience saw a big move last session, as the company’s shares fell by nearly 6% which continued the recent downtrend
VIVO: 16.64 (-0.24), ABAX: 55.15 (+0.95), GWPH: 75.46 (+0.14), OSUR: 9.06 (-0.12)
Medical Marijuana Receives Mixed Signals With This Latest Study
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 10:44AM CST
Source: Flickr user Matthew Kenwrick. The results of the midterm elections were mixed for supporters of marijuana legalization, though mostly positive. Hopes were high that the states of Oregon and Alaska, as well as Washington, D.C., would...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)
The Important Lesson Learned From Florida's Medical Marijuana Vote
Sean Williams, The Motley Fool - Motley Fool - Sat Nov 08, 11:26AM CST
Source: Flickr user Mark. Midterm elections may be over, but that doesn't mean the number of issues that Congress and individual states are yet to tackle have been moved to the back burner. One particular hot-button issue that took center stage...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14)
3 Approve Marijuana Measures, but Florida Passes on Pot
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:09AM CST
Source: Architect of the Capitol, Flickr. Marijuana advocates are cheering the approval of recreational marijuana in Oregon, Alaska, and the District of Columbia, but supporters in Florida will need to shift their focus to 2016. Marijuana is...
INSY: 38.14 (-1.51), GWPH: 75.46 (+0.14), LVS: 63.01 (+1.44)
Allscripts Healthcare Q3 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:30PM CST
Allscripts Healthcare Solutions, Inc. (MDRX) posted adjusted earnings of 2 cents per share in the third quarter of 2014 which missed the Zacks Consensus Estimate by 3 cents.
GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), MDRX: 12.35 (+0.40), MRGE: 3.15 (+0.02)
Wright Medical Posts Wider Q3 Loss; Lowers '14 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:50AM CST
Following the earnings release, shares of Wright Medical Group Inc. (WMGI) dropped nearly 5.7% to close at $28.44 yesterday.
BSX: 13.38 (-0.03), WMGI: 28.59 (+0.39), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), HSP: 57.87 (-0.22)
Novus MedPlan Cost-Saving Provider Network Offers A Strong Value Proposition
ACCESSWIRE - Fri Nov 07, 8:01AM CST
WHITEFISH, MT / ACCESSWIRE / November 7, 2014 / Marijuana reform was a key ballot initiative in seven states (as well as 17 municipalities and D.C.) this week, with more drug policy reform questions (most aimed at reforming or out outright repealing marijuana laws) on the ballot than at any time in the history of the country. In California, Proposition 47 was passed, transforming the lowest-level non-violent crimes like simple drug possession, from a felony to a misdemeanor, freeing up an estimated $1B per annum to be dedicated to useful things like crime prevention, school funding, mental health treatment, and victim services. Regulatory reforms like this are opening up sizable markets for both private and public sector participants.
GWPH: 75.46 (+0.14)
Cannagrow Holdings, Inc. (CGRW) Establishes Itself As a Leader In Colorado's Expanding Cannabis Industry
ACCESSWIRE - Thu Nov 06, 7:01AM CST
Salt Lake City, UT / ACCESSWIRE / November 6, 2014 / As Cannagrow Holdings, Inc. (CGRW) further establishes itself in Colorado and strengthens its association with licensed cannabis growers in the region, cannabis measures voted into law on election day in several states should place CGRW in an ideal position to see substantial gains in a cannabis market that could prove to be far larger than anyone could have predicted over the next two to three years.
GWPH: 75.46 (+0.14)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 69.38 (+0.88), GWPH: 75.46 (+0.14), ABAX: 55.18 (+0.98), COV: 93.87 (+0.99)
Strength Seen in Sophiris Bio (SPHS): Stock Soars 25% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:46AM CST
Sophiris Bio (SPHS) was a big mover last session, as the company saw its shares surge 25% on the day.
ICUI: 84.00 (-0.73), ABAX: 55.18 (+0.98), GWPH: 75.46 (+0.14), SPHS: 2.55 (-0.07)
(0)
(0)GW Pharmaceuticals (GWPH) Stock Research Links
Scroll down for more posts ▼